» Articles » PMID: 34435833

Effect of Alcohol, Tobacco, and Cannabis Co-use on Gray Matter Volume in Heavy Drinkers

Overview
Specialties Psychiatry
Psychology
Date 2021 Aug 26
PMID 34435833
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Alcohol, tobacco, and cannabis are the three most frequently used drugs in the United States and co-use is common. Alcohol, tobacco, and cannabis use has been separately associated with altered brain structure, and alcohol and tobacco co-use results in decreases in gray matter volume. Less is known about the effect of alcohol and cannabis co-use, and alcohol, tobacco, and cannabis tri-use. Therefore, this study examined the effect of co- and tri-use on gray matter volume, a measure of brain cell density, in heavy drinkers.

Method: Heavy drinkers ( = 237; 152m/85f; age = 32.52; white = 111; black = 28; Latino = 9; American Indian = 2; Pacific Islander = 4; Asian = 59; mixed = 15; other = 9) were classified into four groups based on their alcohol, tobacco, and cannabis use: alcohol only users ( = 70), alcohol and tobacco co-users ( = 90), alcohol and cannabis co-users ( = 35), and alcohol, tobacco, and cannabis tri-users ( = 42). All participants completed a structural MRI scan. Voxel-based morphometry was conducted to evaluate the effect of co-use on gray matter volume, with alcohol only users as the reference group. Age, sex, and scanner were included as covariates.

Results: Alcohol and tobacco co-users had significantly decreased left orbitofrontal gray matter volume relative to alcohol only users (Cohen's = .79). There were no differences in gray matter volume between the alcohol only and alcohol and cannabis co-users, or between the alcohol only and tri-user groups.

Conclusion: The additive effect of tobacco co-use on gray matter volumes in heavy drinkers was limited and localized. The effect of tri-use of alcohol, tobacco, and cannabis may have interacted, such that overlapping cannabis and tobacco use masked volume differences present in separate co-using groups. (PsycInfo Database Record (c) 2021 APA, all rights reserved).

Citing Articles

The effects of alcohol use severity and polygenic risk on gray matter volumes in young adults.

Chen Y, Li H, Luo X, Li G, Ide J, Li C medRxiv. 2025; .

PMID: 39974144 PMC: 11838964. DOI: 10.1101/2025.01.20.25320842.


Association Between Cannabis Use and Brain Structures: A Mendelian Randomization Study.

Li J, Yin Z, Yu Z, Li J, Yang L Cureus. 2024; 16(8):e65922.

PMID: 39221390 PMC: 11365007. DOI: 10.7759/cureus.65922.


Regional cortical brain volumes at treatment entry relates to post treatment WHO risk drinking levels in those with alcohol use disorder.

Durazzo T, Stephens L, Kraybill E, May A, Meyerhoff D Drug Alcohol Depend. 2024; 255:111082.

PMID: 38219355 PMC: 10895709. DOI: 10.1016/j.drugalcdep.2024.111082.


The role of sex in daily levels of high-risk alcohol and cannabis co-use.

McManus K, Venegas A, Henry B, Cooper Z, Grodin E, Ray L Drug Alcohol Depend Rep. 2023; 9:100203.

PMID: 38035048 PMC: 10681919. DOI: 10.1016/j.dadr.2023.100203.


Associations of daily alcohol, cannabis, combustible tobacco, and e-cigarette use with same-day co-use and poly-use of the other substances.

Sokolovsky A, Rubenstein D, Gunn R, White H, Jackson K Drug Alcohol Depend. 2023; 251:110922.

PMID: 37625332 PMC: 10538395. DOI: 10.1016/j.drugalcdep.2023.110922.


References
1.
Winters K, Lee C . Likelihood of developing an alcohol and cannabis use disorder during youth: association with recent use and age. Drug Alcohol Depend. 2007; 92(1-3):239-47. PMC: 2219953. DOI: 10.1016/j.drugalcdep.2007.08.005. View

2.
Anton R, Moak D, Latham P . The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol Clin Exp Res. 1995; 19(1):92-9. DOI: 10.1111/j.1530-0277.1995.tb01475.x. View

3.
Glass J, Adams K, Nigg J, Wong M, Puttler L, Buu A . Smoking is associated with neurocognitive deficits in alcoholism. Drug Alcohol Depend. 2005; 82(2):119-26. PMC: 2261373. DOI: 10.1016/j.drugalcdep.2005.08.013. View

4.
Burns H, Van Laere K, Sanabria-Bohorquez S, Hamill T, Bormans G, Eng W . [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor. Proc Natl Acad Sci U S A. 2007; 104(23):9800-5. PMC: 1877985. DOI: 10.1073/pnas.0703472104. View

5.
Courtney K, Ray L . Subjective responses to alcohol in the lab predict neural responses to alcohol cues. J Stud Alcohol Drugs. 2014; 75(1):124-35. PMC: 3893626. DOI: 10.15288/jsad.2014.75.124. View